IL22 and graft versus host disease: Due to the degree of MHC disparity, bone marrow (BM) and T-cell doses, genetic manipulation of specific cell populations, and control of the microbiome environment, paradoxical results were observed regarding the role of IL-22 in experimental GVHD.